Vaccitech plc - ROE
VACC
Price:
$5
Market Cap:
$27.05M
Vaccitech plc is a clinical-stage biopharmaceutical company focused on developing cutting-edge T-cell immunotherapeutics and vaccines. Their mission is to treat and prevent a variety of infectious diseases and cancers. The company's therapeutic pipeline includes several programs undergoing clinical evaluation: VTP-300 is in Phase 1/2a clinical trials for chronic hepatitis B. VTP-200 is also in Phase 1/2a development, targeting human papillomavirus (HPV) infection. VTP-850 is progressing through Phase 1/2 clinical studies for prostate cancer. VTP-600 is engaged in Phase 1/2a trials for non-small cell lung cancer. In terms of prevention, their prophylactic initiatives feature: VTP-400, which i...[Read more]
Industry
Biotechnology
IPO Date
2021-04-30
Stock Exchange
NASDAQ
Ticker
VACC
PE Ratio
[-3.45]
ROE
[-63.87%]
Current Ratio
[6.05]
Dividend Yield
[0%]
Enterprise Value
[-29134949.00]
Dividend History
The ROE as of June 2026 (TTM) for Vaccitech plc (VACC) is -63.87%
According to Vaccitech plc’s latest financial reports and current stock price. The company's current ROE is -63.87%. This represents a change of 318.02% compared to the average of -15.28% of the last 4 quarters.
Vaccitech plc (VACC) Historical ROE (quarterly & annually)
How has VACC ROE performed in the past?
The mean historical ROE of Vaccitech plc over the last ten years is 56.98%. The current -63.87% ROE has changed -212.09% with respect to the historical average. Over the past ten years (40 quarters), VACC's ROE was at its highest in in the December 2020 quarter at 295.51%. The ROE was at its lowest in in the June 2025 quarter at -20.63%.
Average
56.98%
Median
-20.17%
Minimum
-89.73%
Maximum
500.45%
Vaccitech plc (VACC) ROE by Quarter and Year
Discovering the peaks and valleys of Vaccitech plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 441.90%
Maximum Annual ROE = 500.45%
Minimum Annual Increase = -1885.50%
Minimum Annual ROE = -89.73%
| Year | ROE | Change |
|---|---|---|
| 2025 | -89.73% | 91.03% |
| 2024 | -46.97% | 19.61% |
| 2023 | -39.27% | -1885.50% |
| 2022 | 2.20% | -110.90% |
| 2021 | -20.17% | -104.03% |
| 2020 | 500.45% | 441.90% |
Vaccitech plc (VACC) Average ROE
How has VACC ROE performed in the past?
The current ROE of Vaccitech plc (VACC) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-58.65%
5-year avg
-38.79%
10-year avg
56.98%
Vaccitech plc (VACC) ROE vs. Peers
How is VACC’s ROE compared to its peers?
Vaccitech plc’s ROE is greater than LakeShore Biopharma Co., Ltd (-18.43%), greater than Theseus Pharmaceuticals, Inc. (-20.74%), greater than Spectrum Pharmaceuticals, Inc. (-207.06%), less than Zevra Therapeutics, Inc. (81.34%), greater than Alaunos Therapeutics, Inc. (-165.94%), greater than LENZ Therapeutics, Inc. (-46.82%), greater than F-star Therapeutics, Inc. (-44.74%), greater than CARGO Therapeutics, Inc. Common Stock (-61.29%), greater than Acelyrin, Inc. (-31.03%), less than Selecta Biosciences, Inc. (194.13%),
| Company | ROE | Market cap |
|---|---|---|
| -18.43% | $25.84M | |
| -20.74% | $181.50M | |
| -207.06% | $210.38M | |
| 81.34% | $762.58M | |
| -165.94% | $5.25M | |
| -46.82% | $192.83M | |
| -44.74% | $156.51M | |
| -61.29% | $216.19M | |
| -31.03% | $229.17M | |
| 194.13% | $135.20M |
Build a custom stock screener for Vaccitech plc (VACC) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaccitech plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Vaccitech plc (VACC) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Vaccitech plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Vaccitech plc's ROE?
How is the ROE calculated for Vaccitech plc (VACC)?
What is the highest ROE for Vaccitech plc (VACC)?
What is the 3-year average ROE for Vaccitech plc (VACC)?
What is the 5-year average ROE for Vaccitech plc (VACC)?
How does the current ROE for Vaccitech plc (VACC) compare to its historical average?